{"id":51,"date":"2022-01-24T12:13:19","date_gmt":"2022-01-24T03:13:19","guid":{"rendered":"https:\/\/e-nabio.co.jp\/en\/?page_id=51"},"modified":"2024-06-07T10:21:49","modified_gmt":"2024-06-07T01:21:49","slug":"aboutus","status":"publish","type":"page","link":"https:\/\/e-nabio.co.jp\/en\/aboutus\/","title":{"rendered":"ABOUT US"},"content":{"rendered":"<div class=\"about_page\">\r\n<div class=\"page_inner\">\r\n<div class=\"width_adjust\">\r\n<section class=\"about-us_sec\">\r\n<h2 class=\"about_h2\"><span>ABOUT US<\/span><\/h2>\r\n<div class=\"flex\">\r\n<div class=\"item\"><img decoding=\"async\" src=\"\/struct\/wp-content\/uploads\/about02.jpg\" alt=\"we aims to bring microRNA medicine (nucleic acid medicine) to the market and patient.\" \/><\/div>\r\n<div class=\"item\">\r\n<p class=\"txt\">e-NA Biotec Inc. is a drug discovery bio-venture company originating from Gifu University. Based on the research results of professors both, Dr. KITADE and Dr. AKAO at Gifu University for many years, we aim to bring microRNA medicine (nucleic acid medicine) to the market and patients.<\/p>\r\n<p class=\"txt mt\">Our company was established on January 11, 2018 under program for creating start-ups from advanced research and technology (START) supported by the National Institute of Science and Technology Agency (JST) in Japan.<\/p>\r\n<p class=\"txt mt\">In the field of nucleic acid medicine, where exponential design exists, we are continuing research and development of the world's first Ras-targeted microRNA medicine using highly chemically modified microRNAs discovered by utilizing our know-how.<\/p>\r\n<\/div>\r\n<\/div>\r\n<\/section>\r\n<section class=\"about-us_sec mission_sec\">\r\n<h2 class=\"about_h2\"><span>MISSION<\/span><\/h2>\r\n<div class=\"flex\">\r\n<div class=\"item\"><img decoding=\"async\" src=\"\/struct\/wp-content\/uploads\/mission.jpg\" alt=\"Through our business, we believe that we can improve the quality of life of patients and contribute to society by creating a new future based on science, based on the knowledge we have gained through our long-standing research on nucleic acids.\" \/><\/div>\r\n<div class=\"item\">\r\n<p class=\"txt\">MicroRNAs are biomolecules that regulate our individual gene expression in the cell. More than 2600 microRNAs have already been reported in the humans (from miRBase, as of April 2024).<\/p>\r\n<p class=\"txt mt\">It is believed that an imbalance in the amount of microRNAs in a cell causes cancer and other diseases.<br \/>\r\nWe are focused on microRNAs as potential therapeutics, particularly for unmet or refractory cancers with few treatment options.<\/p>\r\n<p class=\"txt mt\">Our mission is to advance microRNA drug candidates (seeds) into preclinical and clinical trials as quickly as possible and to make therapeutics available to patients worldwide with unmet medical needs.<br \/>\r\nThrough our business, we believe that we can improve the quality of life for patients and contribute to society by creating a new future based on science, based on the knowledge we have gained from our many years of research on nucleic acids.<\/p>\r\n<\/div>\r\n<\/div>\r\n<\/section>\r\n<section class=\"profile_sec\">\r\n<h2 class=\"about_h2\"><span>COMPANY PROFILE<\/span><\/h2>\r\n<table class=\"profile_table responsive\">\r\n<tbody>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Name of the Company<\/th>\r\n<td style=\"width: 767px;\">e-NA Biotec Inc.<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Foundation<\/th>\r\n<td style=\"width: 767px;\">11th of Jan, 2018 supported by JST's START project<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Location<\/th>\r\n<td style=\"width: 767px;\">#302 3-12-3, Inaba St. Gifu city, 500-8043 JAPAN<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Representative<\/th>\r\n<td class=\"flex\" style=\"width: 766px;\">\r\n<div class=\"item\"><img decoding=\"async\" src=\"\/en\/wp-content\/uploads\/bec938884c891c9b06493e79d0c77df7.png\" alt=\"Yukio KITADE, phD, CEO\" \/><\/div>\r\n<div class=\"item\">\r\n<p class=\"name\">Yukio KITADE, PhD, CEO<\/p>\r\n<ul>\r\n\t<li>-Professor, Faculty of Engineering, Gifu University, 2001-2016<br \/>\r\n-Emeritus Professor, Gifu University, 2016<br \/>\r\n-Specially Appointed Professor, Gifu University since 2016\u00a0<br \/>\r\n-Professor, Faculty of Engineering, Aichi Institute of Technology also since 2016<br \/>\r\n-CEO, e-NA Biotec Inc. since 2018<\/li>\r\n<\/ul>\r\n<\/div>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">\r\n<p>Special Chief Advisor\/<\/p>\r\n<p>Principal Scientist<\/p>\r\n<\/th>\r\n<td style=\"width: 767px;\">\r\n<p class=\"name\">Yukihiro AKAO, MD, PhD<\/p>\r\n<ul>\r\n\t<li>Emeritus Professor, Gifu University<\/li>\r\n\t<li>Specialty: Molecular genetics, Oncology and Cancer prevention<\/li>\r\n\t<li>He still conducts microRNA and phytochemical research.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Scientific Advisor<\/th>\r\n<td style=\"width: 767px;\">\r\n<p class=\"name\">Tsuyoshi YOKOI, PhD<\/p>\r\n<ul>\r\n\t<li>Specialty: Toxicogenomics<\/li>\r\n\t<li>Emeritus Professor, Nagoya University \/ Emeritus Professor, Kanazawa University<\/li>\r\n\t<li>He currently serves as an advisor to some pharmaceutical companies and as an extramural committee member for clinical research at universities.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Technical Advisor<\/th>\r\n<td style=\"width: 767px;\">\r\n<p class=\"name\">Hideo MARUHASHI, PhD<\/p>\r\n<ul>\r\n\t<li>Specialty: Commercial production of active pharmaceutical ingredients (APIs), investigational new drugs (INDs), and intermediates (small-scale to scale-up manufacturing)<\/li>\r\n\t<li>Advisor, Sanwa Chemiphar Corporation \/ Advisor, Ace Japan Inc.<\/li>\r\n\t<li>He was formerly at Wako Pure Chemical Industries, Taiho Pharmaceutical Industries, Mitsubishi Corporation, etc.<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 272.25px;\">Scientific Advisor<\/th>\r\n<td style=\"width: 767px;\">\r\n<p class=\"name\"><span>Mahmoud Kandeel, DVM, PhD<\/span><\/p>\r\n<p><span>Doctor of Veterinary Medicine\uff08DVM\uff09<br \/>\r\n<\/span><span style=\"font-size: 14.88px; text-align: justify; background-color: transparent;\">Specialty: Molecular biology<\/span><\/p>\r\n<ul>\r\n\t<li>\r\n<p><span>Kafrelsheikh University,\u00a0Egypt<\/span><\/p>\r\n<p><span>King Faisal University, Saudi Arabia<\/span><\/p>\r\n<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<p>&nbsp;<\/p>\r\n<\/section>\r\n<\/div>\r\n<\/div>\r\n<\/div>","protected":false},"excerpt":{"rendered":"ABOUT US e-NA Biotec Inc. is a drug discovery bio-venture company originating from Gifu University. Based on t ...","protected":false},"author":2,"featured_media":235,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"page-nosidebar-fullthumb-h1.php","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-51","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/pages\/51","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/comments?post=51"}],"version-history":[{"count":25,"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/pages\/51\/revisions"}],"predecessor-version":[{"id":307,"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/pages\/51\/revisions\/307"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/media\/235"}],"wp:attachment":[{"href":"https:\/\/e-nabio.co.jp\/en\/wp-json\/wp\/v2\/media?parent=51"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}